Mechanisms of initiation and progression of intestinal fibrosis in IBD
Authors:
- Giovanni LatellaGLGiovanni Latella
- Jacopo Di GregorioJGJacopo Di Gregorio
- Vincenzo FlatiVincenzo Flati
- Florian RiederFRFlorian Rieder
- Ian C. LawranceILIan C. Lawrance
- 19 December 2014
- journal article
- review article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 50 (1) , 53-65
Abstract
Intestinal fibrosis is a common complication of the inflammatory bowel diseases (IBDs). It becomes clinically apparent in >30% of patients with Crohn's disease (CD) and in about 5% with ulcerative colitis (UC). Fibrosis is a consequence of local chronic inflammation and is characterized by excessive extracellular matrix (ECM) protein deposition. ECM is produced by activated myofibroblasts, which are modulated by both, profibrotic and antifibrotic factors. Fibrosis depends on the balance between the production and degradation of ECM proteins. This equilibrium can be impacted by a complex and dynamic interaction between profibrotic and antifibrotic mediators. Despite the major therapeutic advances in the treatment of active inflammation in IBD over the past two decades, the incidence of intestinal strictures in CD has not significantly changed as the current anti-inflammatory therapies neither prevent nor reverse the established fibrosis and strictures. This implies that control of intestinal inflammation does not necessarily affect the associated fibrotic process. The conventional view that intestinal fibrosis is an inevitable and irreversible process in patients with IBD is also gradually changing in light of an improved understanding of the cellular and molecular mechanisms that underline the pathogenesis of fibrosis. Comprehension of the mechanisms of intestinal fibrosis is thus vital and may pave the way for the developments of antifibrotic agents and new therapeutic approaches in IBD.Keywords
This publication has 95 references indexed in Scilit:
- Mechanisms of Tissue Remodeling in Inflammatory Bowel DiseaseDigestive Diseases, 2013
- Crohn's disease complicated by strictures: a systematic reviewGut, 2013
- Mechanisms of fibrosis: therapeutic translation for fibrotic diseaseNature Medicine, 2012
- Crucial steps in the natural history of inflammatory bowel diseaseWorld Journal of Gastroenterology, 2012
- Themes in fibrosis and gastrointestinal inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2011
- Epidemiology and Natural History of Inflammatory Bowel DiseasesGastroenterology, 2011
- NOD2/CARD15,ATG16L1andIL23Rgene polymorphisms and childhood-onset of Crohn’s diseaseWorld Journal of Gastroenterology, 2010
- Intestinal fibrosis in IBD—a dynamic, multifactorial processNature Reviews Gastroenterology & Hepatology, 2009
- Fibrogenesis in Crohn's DiseaseAmerican Journal of Gastroenterology, 2007
- Inflammation Location, But Not Type, Determines the Increase in TGF-β1 and IGF-1 Expression and Collagen Deposition in IBD IntestineInflammatory Bowel Diseases, 2001